Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract
- PMID: 33081421
- PMCID: PMC7589079
- DOI: 10.3390/v12101174
Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract
Abstract
To address the expression pattern of the SARS-CoV-2 receptor ACE2 and the viral priming protease TMPRSS2 in the respiratory tract, this study investigated RNA sequencing transcriptome profiling of samples of airway and oral mucosa. As shown, ACE2 has medium levels of expression in both small airway epithelium and masticatory mucosa, and high levels of expression in nasal epithelium. The expression of ACE2 is low in mucosal-associated invariant T (MAIT) cells and cannot be detected in alveolar macrophages. TMPRSS2 is highly expressed in small airway epithelium and nasal epithelium and has lower expression in masticatory mucosa. Our results provide the molecular basis that the nasal mucosa is the most susceptible locus in the respiratory tract for SARS-CoV-2 infection and consequently for subsequent droplet transmission and should be the focus for protection against SARS-CoV-2 infection.
Keywords: ACE2; COVID-19; SARS-CoV-2; TMPRSS2.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.Nat Commun. 2020 Oct 12;11(1):5139. doi: 10.1038/s41467-020-18781-2. Nat Commun. 2020. PMID: 33046696 Free PMC article.
-
Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.Emerg Microbes Infect. 2020 Dec;9(1):2169-2179. doi: 10.1080/22221751.2020.1827985. Emerg Microbes Infect. 2020. PMID: 32969768 Free PMC article.
-
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.Eur Respir J. 2020 Sep 3;56(3):2001123. doi: 10.1183/13993003.01123-2020. Print 2020 Sep. Eur Respir J. 2020. PMID: 32675206 Free PMC article.
-
ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.Biomed Pharmacother. 2020 Nov;131:110678. doi: 10.1016/j.biopha.2020.110678. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861070 Free PMC article. Review.
-
Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics.Respir Res. 2020 Sep 29;21(1):252. doi: 10.1186/s12931-020-01521-x. Respir Res. 2020. PMID: 32993656 Free PMC article. Review.
Cited by
-
Structural understanding of SARS-CoV-2 virus entry to host cells.Front Mol Biosci. 2023 Nov 2;10:1288686. doi: 10.3389/fmolb.2023.1288686. eCollection 2023. Front Mol Biosci. 2023. PMID: 38033388 Free PMC article. Review.
-
Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19.Life Sci Alliance. 2021 Aug 5;4(10):e202000954. doi: 10.26508/lsa.202000954. Print 2021 Oct. Life Sci Alliance. 2021. PMID: 34353886 Free PMC article.
-
Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.Am J Physiol Cell Physiol. 2020 Aug 1;319(2):C258-C267. doi: 10.1152/ajpcell.00224.2020. Epub 2020 Jun 8. Am J Physiol Cell Physiol. 2020. PMID: 32510973 Free PMC article.
-
Immediate myeloid depot for SARS-CoV-2 in the human lung.Sci Adv. 2024 Aug 2;10(31):eadm8836. doi: 10.1126/sciadv.adm8836. Epub 2024 Jul 31. Sci Adv. 2024. PMID: 39083602 Free PMC article.
-
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences.Front Immunol. 2023 Aug 17;14:1244556. doi: 10.3389/fimmu.2023.1244556. eCollection 2023. Front Immunol. 2023. PMID: 37662901 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous